External pharmaceutical composition

A technology of external drug and composition, which is applied in the field of external drug composition, can solve the problems of increased application, achieve the effect of less restriction, relieve or cure deformed joint disease, and excellent storage stability

Active Publication Date: 2017-02-15
KOBAYASHI PHARMA CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When diclofenac is administered orally or rectally, gastrointestinal, renal, or hepatic damage may occur as a side effect, and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External pharmaceutical composition
  • External pharmaceutical composition
  • External pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to view more

PUM

No PUM Login to view more

Abstract

To provide a pharmaceutical technique which inhibits yellowing caused under temporal or high temperature conditions, while containing diclofenac and/or a salt thereof and tocopherol and/or a derivative thereof, in an external pharmaceutical composition which contains water, to enable having an excellent storage stability. In an external pharmaceutical composition containing diclofenac and/or a salt thereof, tocopherol and/or a derivative thereof, and water, containing lactic acid and/or a salt thereof can inhibit yellowing caused under temporal or high temperature conditions to enable having an excellent storage stability.

Description

technical field [0001] The present invention relates to an external pharmaceutical composition containing diclofenac and / or a salt thereof, tocopherol and / or a derivative thereof, and water, which suppresses yellowing over time or under high temperature conditions and has excellent storage stability. Background technique [0002] In modern society, the number of people suffering from shoulder pain, muscle pain, joint pain, etc. has increased due to the same posture for a long time, excessive stress, and lack of exercise due to the spread of OA equipment. Conventionally, for such shoulder pain, muscle and joint pain, etc., anti-inflammatory analgesics have been applied in order to suppress inflammation in the affected area and improve symptoms. [0003] Conventionally, non-steroidal anti-inflammatory drugs such as diclofenac, felbinac, dexamethasone, indomethacin, and ibuprofen have been put into practical use as anti-inflammatory analgesics. Among these non-steroidal anti-i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/196A61K9/08A61K31/355A61K47/10A61K47/12A61P19/02A61P29/00A61P43/00
CPCA61K47/10A61K47/12A61K9/08A61K31/196A61K31/355A61K9/0014A61K31/19A61P19/02A61P29/00A61P43/00A61K2300/00
Inventor 阿度和克今井歌子薇
Owner KOBAYASHI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products